• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE 035 PTA BALLOON DILATATION CATHETER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE 035 PTA BALLOON DILATATION CATHETER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number U357574
Medical Device Problem Codes Retraction Problem (1536); Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 09/01/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
No hospital/medical records or medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
 
Event or Problem Description
It was reported that during an angioplasty procedure of a tight stenosis in the cephalic vein, the pta balloon allegedly ruptured between 10 and 11 atm on the first inflation.It was further reported that the health care provider had difficulty retracting the balloon through the 7fr sheath.The pta balloon was exchanged over the guidewire for another that was used to complete the procedure.There was no reported patient injury.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records were reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Conclusion: the device was returned for evaluation.A visual inspection found a complete compound rupture in the approximate middle of the balloon.Therefore, the investigation is confirmed for the reported rupture.However, the investigation is inconclusive for the reported retraction issue, as the device was not able to be fully functionally tested due to the identified rupture.The balloon rupture likely lead to the retraction issues.However, the definitive root cause for the balloon rupture or retraction issues could not be determined based upon the available information.Per the reported event details, a 10ml syringe was used to inflate the balloon.The instructions for use states that a pressure monitoring device is recommended to avoid over pressurization.It is unknown if procedural issues or over pressurization of the balloon contributed to the reported event.Labeling review: the current ifu (instructions for use) states: warnings: do not exceed the rbp recommended for this device.Balloon rupture may occur if the rbp rating is exceeded.To prevent over pressurization, use of a pressure monitoring device is recommended.Precautions: if resistance is felt during post procedure withdrawal of the catheter through the introducer sheath/guide catheter, determine if contrast is trapped in the balloon with fluoroscopy.If contrast is present, push the balloon out of the introducer sheath/guide catheter and then completely evacuate the contrast before proceeding to withdraw the balloon.If resistance is still felt during post procedure withdrawal of the catheter, it is recommended to remove the balloon catheter and introducer sheath/guide catheter as a single unit.Use of the ultraverse 035 pta dilatation catheter: position the balloon relative to the lesion to be dilated, ensure the guidewire is in place, and inflate the balloon to the appropriate pressure.Potential adverse reactions: additional intervention.(b)(4).
 
Event or Problem Description
It was reported that during an angioplasty procedure of a tight stenosis in the cephalic vein, the pta balloon allegedly ruptured between 10 and 11 atm on the first inflation.It was further reported that the health care provider had difficulty retracting the balloon through the 7fr sheath.The pta balloon was exchanged over the guidewire for another that was used to complete the procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAVERSE 035 PTA BALLOON DILATATION CATHETER
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key6949109
Report Number2020394-2017-01337
Device Sequence Number796131
Product Code LIT
UDI-Device Identifier00801741093456
UDI-Public(01)00801741093456
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K142261
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2020
Device Model NumberU357574
Device Catalogue NumberU357574
Device Lot NumberCMBS0110
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/26/2017
Initial Date Received by Manufacturer 09/18/2017
Supplement Date Received by Manufacturer11/27/2017
Initial Report FDA Received Date10/13/2017
Supplement Report FDA Received Date12/19/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age62 YR
Patient Weight95
-
-